Duloxetine-Associated Photodistributed Erythema Multiforme

Prim Care Companion CNS Disord. 2022 May 5;24(3):21cr02983. doi: 10.4088/PCC.21cr02983.

Authors

Paulina Gay¹, Sebastián Niezen¹, Brenda Sáenz-Dávila¹, Ivonne Arellano-Mendoza¹, Patricia Mercadillo¹, Andrés Tirado-Sánchez^{1

2}

Affiliations

¹ Department of Dermatology, Hospital General de México, Mexico City, Mexico.
² Corresponding author: Andrés Tirado-Sánchez, MD, PhD, Servicio de Dermatología, Hospital General de México, Dr Balmis 148, Col. Doctores, Deleg. Cuauhtemoc, México, D.F. C.p. 06726 (atsdermahgm@gmail.com).

PMID: 35522835
DOI: 10.4088/PCC.21cr02983

No abstract available

© Copyright 2022 Physicians Postgraduate Press, Inc.

MeSH terms

Duloxetine Hydrochloride / adverse effects
Erythema Multiforme* / chemically induced
Erythema Multiforme* / diagnosis
Humans

Substances

Duloxetine Hydrochloride